These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16027426)

  • 21. Humanized antibodies as potential drugs for therapeutic use.
    Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
    Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of second generation JE vaccine with genetic engineering techniques.
    Manabe S
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):643-6. PubMed ID: 2561720
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceutical nanoparticles--from their innovative origin to their future.
    Müller RH; Keck CM
    Int J Pharm; 2010 May; 390(1):1-2. PubMed ID: 20153816
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic monoclonal antibodies: knowledge transfer from Inserm].
    Perrin-Wolff M; Cans C
    Med Sci (Paris); 2009 Dec; 25(12):1193-5. PubMed ID: 20035705
    [No Abstract]   [Full Text] [Related]  

  • 25. Engineering monoclonal antibodies.
    Rodwell JD
    Nature; 1989 Nov; 342(6245):99-100. PubMed ID: 2682259
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DR's orders: human antibody kills tumors by direct signaling.
    Longo DL
    Nat Med; 2002 Aug; 8(8):781-3. PubMed ID: 12152028
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cellular immunotherapy for brain tumors].
    Kikuchi T
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():546-50. PubMed ID: 16201579
    [No Abstract]   [Full Text] [Related]  

  • 29. The challenge of integrating monoclonal antibodies into the current healthcare system.
    Brixner DI; Bull SA
    Am J Manag Care; 1997 Jun; 3(6):903-11. PubMed ID: 10170294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic engineering].
    Candeias JA
    Rev Saude Publica; 1991 Feb; 25(1):3-10. PubMed ID: 1784958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Directed evolution for drug and nucleic acid delivery.
    Hida K; Hanes J; Ostermeier M
    Adv Drug Deliv Rev; 2007 Dec; 59(15):1562-78. PubMed ID: 17933418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Getting genes where we want them.
    Kent-First M; First N
    Nat Biotechnol; 2000 Sep; 18(9):928-9. PubMed ID: 10973206
    [No Abstract]   [Full Text] [Related]  

  • 33. Gene technologies for antibody engineering.
    Winter G
    Behring Inst Mitt; 1990 Dec; (87):10-20. PubMed ID: 2096816
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic antibody gene transfer.
    Marasco WA
    Nat Biotechnol; 2005 May; 23(5):551-2. PubMed ID: 15877069
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetically engineered monoclonal antibodies.
    Clackson TP
    Br J Rheumatol; 1991; 30 Suppl 2():36-9. PubMed ID: 1993256
    [No Abstract]   [Full Text] [Related]  

  • 36. "Active" cancer immunotherapy by anti-Met antibody gene transfer.
    Vigna E; Pacchiana G; Mazzone M; Chiriaco C; Fontani L; Basilico C; Pennacchietti S; Comoglio PM
    Cancer Res; 2008 Nov; 68(22):9176-83. PubMed ID: 19010889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic engineering including superseding microinjection: new ways to make GM pigs.
    Galli C; Perota A; Brunetti D; Lagutina I; Lazzari G; Lucchini F
    Xenotransplantation; 2010; 17(6):397-410. PubMed ID: 21158942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deal watch: BMS bets on biologic immunotherapies.
    Nat Rev Drug Discov; 2009 Sep; 8(9):688-9. PubMed ID: 19721438
    [No Abstract]   [Full Text] [Related]  

  • 39. Formulation and delivery issues for monoclonal antibody therapeutics.
    Daugherty AL; Mrsny RJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):686-706. PubMed ID: 16839640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene delivery from polymer scaffolds for tissue engineering.
    Jang JH; Houchin TL; Shea LD
    Expert Rev Med Devices; 2004 Sep; 1(1):127-38. PubMed ID: 16293016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.